Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Now consider what was said in the shareholders meeting, about whether a PR disclosing a dollar amount being released. The $225M-250M number was thrown out.

I was at the SHM, and I'm pretty sure the amount was $250M and that it was said by Mr. Pohl.

SDC

Share
New Message
Please login to post a reply